Lansoprazole Capsule, Delayed Release
Product Images NDC 33342-310

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 33342-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Lansoprazole Figure 1)

A line graph depicting the mean severity of day heartburn over days from the start of treatment for patients taking placebo, Lansoprazole 15 mg, and Lansoprazole 30 mg. The x-axis represents days from start of treatment (0 to 60), and the y-axis represents mean severity of day heartburn (0 to 2.5). The graph shows a decrease in heartburn severity over time, with Lansoprazole groups demonstrating lower severity compared to placebo.*

FDA Label Image

Fig-2 (Lansoprazole Figure 2)

A line graph titled 'Mean Severity of Night Heartburn By Study Day For Evaluable Patients' showing changes in heartburn severity scores over 60 days of treatment. It compares placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily, with severity scores on the vertical axis and days on the horizontal axis.*

FDA Label Image

Lansoprazole-structure (Lansoprazole Structure)

Chemical structure of lansoprazole, illustrating the arrangement of atoms including a benzimidazole ring, sulfoxide group, and substituted pyridine ring with trifluoromethoxy and methyl groups attached.*

FDA Label Image

546 (Lansoprazole Tablets 15 mg 30s)

Lansoprazole 15 mg delayed-release capsules, oral dosage form, shown in a white label for 30 capsules. The label includes the NDC 33342-310-07, manufacturer Macleods Pharmaceuticals Limited, and distributor Macleods Pharma USA, Inc. It provides storage instructions and pharmacist dispensing information.*

FDA Label Image

657 (Lansoprazole Tablets 30 mg 30s)

Label for Lansoprazole Delayed-Release Capsules USP 30 mg by Macleods Pharmaceuticals Limited. The label displays the product name, strength, dosage form, and quantity of 30 capsules. It includes storage instructions, identification of the capsule appearance, and manufacturer information for Macleods Pharma USA and Macleods Pharmaceuticals Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.